Sökning: onr:"swepub:oai:DiVA.org:umu-92378" >
Suicide in schizoph...
Suicide in schizophrenia
-
- Carlborg, Andreas (författare)
- Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, S-17176 Stockholm, Sweden
-
- Winnerbäck, Kajsa (författare)
- Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, S-17176 Stockholm, Sweden
-
- Jönsson, Erik G (författare)
- Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, S-17176 Stockholm, Sweden
-
visa fler...
-
- Jokinen, Jussi (författare)
- Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, S-17176 Stockholm, Sweden
-
- Nordström, Peter (författare)
- Karolinska Inst, Dept Clin Neurosci, Karolinska Univ Hosp, S-17176 Stockholm, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2014-01-09
- 2010
- Engelska.
-
Ingår i: Expert Review of Neurotherapeutics. - : Informa UK Limited. - 1473-7175 .- 1744-8360. ; 10:7, s. 1153-64
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Schizophrenia is a disorder with an estimated suicide risk of 4-5%. Many factors are involved in the suicidal process, some of which are different from those in the general population. Clinical risk factors include attempted suicide, depression, male gender, substance abuse and hopelessness. Biosocial factors, such as a high intelligence quotient and high level of premorbid function, have also been associated with an increased risk of suicide in patients with schizophrenia. Suicide risk is especially high during the first year after diagnosis. Many of the suicides occur during hospital admission or soon after discharge. Management of suicide risk includes both medical treatment and psychosocial interventions. Still, risk factors are crude; efforts to predict individual suicides have not proved useful and more research is needed.
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas